Gregory MSClinical trial: Neurologic Bone Marrow Derived Stem Cell Treatment Study
pub2post"Preparing for Responsible Sharing of Clinical Trial Data"
📊 Data sharing can enhance drug safety and effectiveness analysis
#ClinicalTrials #DataTransparency #PublicHealthScience https://tnyp.me/PVuATQWG/m
Framework for Clinical Data Sharing:
🔍 Independent data analysis detects safety issues.
📈 Pooled data enhances study precision.
https://tnyp.me/4MbHVaxV/m #ClinicalTrials #DataSharing #PublicHealth
Michael HenryI'm building Lantern: cancer research in plain language, for patients and families facing a diagnosis.
Type a diagnosis and it finds clinical trials open and recruiting right now, from ClinicalTrials.gov. Or search PubMed, and it rewrites dense studies in plain words, at a sixth-grade reading level, and tells you how much weight to give each one.
Lantern explains, it never decides. It always points back to your care team. Still a work in progress.
Clinical trial: A Phase 1b Multicenter, Non-randomized, Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of Single Ascending Doses of a New Subcutaneous Formulation of Ocrelizumab in Patients With Multiple Sclerosis
Clinical trial: A PHASE III, OPEN-LABEL, SINGLE-ARM, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND USE OF AN ON-BODY DELIVERY SYSTEM FOR THE SUBCUTANEOUS HOME ADMINISTRATION OF OCRELIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS
Clinical trial: Effect of Specialised Physiotherapy and Supportive Psychotherapy on Clinical Status, Neuroplasticity, and Quality of Life in People With Multiple Sclerosis: A Prospective Interventional Study With a Self-Controlled Design
Genelife Clinical ResearchIndia's #healthcare landscape presents a unique opportunity for #epidemiology research.
With a population of more than 1.4 billion people, remarkable genetic and environmental diversity, and a #DiseaseBurden that spans both infectious diseases and rapidly growing chronic conditions, #India has become one of the world's most valuable environments for #DiseaseSurveillance, #PublicHealth #PostMarketingStudy & #RealWorldEvidence generation. #ClinicalResearch #ClinicalTrials
https://genelifecr.blogspot.com/2026/06/disease-surveillance-and-epidemiology.html
With a population of more than 1.4 billion people, remarkable genetic and environmental diversity, and a #DiseaseBurden that spans both infectious diseases and rapidly growing chronic conditions, #India has become one of the world's most valuable environments for #DiseaseSurveillance, #PublicHealth #PostMarketingStudy & #RealWorldEvidence generation. #ClinicalResearch #ClinicalTrials
https://genelifecr.blogspot.com/2026/06/disease-surveillance-and-epidemiology.html
Clinical trial: An Open-Label Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
Clinical trial: Development of Pain Management Just-In-Time Adaptive Interventions (JITAI) Content in Multiple Sclerosis and Spinal Cord Injury